Table 1.
Characteristic | Sydney Cohort | BOPI Cohort |
---|---|---|
No. of patients included | 21 | 16 |
Age at challenge (mean ± SD) | 5.5 ± 3.7 years | 12.7 ± 2.5 years |
SPT wheal size to commercial peanut extract (median, interquartile range) | 11 mm (6.5–15.5 mm) | 9 mm (6–23 mm) |
Peanut‐specific IgE (kUA/l) | 20.5 (0.86–>100) | 33.9 (0.62–>100) |
IgE to rAra h 2 (kUA/l) | Not done | 13.2 (0.21–>100) |
Gender, no. (%) | ||
Male | 17 (81) | 10 (62) |
Female | 4 (19) | 6 (38) |
Other atopy, no. (%) | ||
Asthma | 7 (33) | 13 (82) |
Allergic rhinitis | 7 (33) | 14 (88) |
Eczema | 13 (62) | 7 (44) |
Other food allergy | 6 (29) | 8 (50) |
Outcome of OFC no. (%) | ||
Anaphylaxis | 21 (100) | 16 (100) |
As initial symptom | 3 (14) | 2 (13) |
SPT, skin prick test; OFC, oral food challenge.